Aark Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 0.75 M
as on 26-06-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -5.01%
(FY 2023)
- Ebitda -82.52%
(FY 2023)
- Net Worth -4.55%
(FY 2023)
- Total Assets -0.05%
(FY 2023)
About Aark Pharmaceuticals India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.75 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Kansal and Geetika Kansal serve as directors at the Company.
- CIN/LLPIN
U24100DL2013PTC260660
- Company No.
260660
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2013
- Date of AGM
27 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aark Pharmaceuticals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kansal  | Director | 23-Nov-2013 | Current |
| Geetika Kansal | Director | 23-Nov-2013 | Current |
Financial Performance of Aark Pharmaceuticals India.
Aark Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 5.01% decrease in profit. The company's net worth dipped by a decrease of 4.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aark Pharmaceuticals India?
Unlock access to Aark Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Health Wander Private LimitedActive 3 months 26 daysSanjeev Kansal and Geetika Kansal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aark Pharmaceuticals India?
Unlock and access historical data on people associated with Aark Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aark Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aark Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
